These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 35470579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G, Ren H, Shang Q, Zhang Z, Zhao W, Yu X, Tang J, Yang Z, Liang D, Jiang X.
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [Abstract] [Full Text] [Related]

  • 3. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y, Zhuang Q, Tao L, Zheng K, Chen S, Yang Y, Feng C, Wang Z, Shi H, Shi J, Fang Y, Xiao L, Geng D, Wang Z.
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [Abstract] [Full Text] [Related]

  • 4. Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
    Tang Y, Lv XL, Bao YZ, Wang JR.
    Climacteric; 2021 Jun; 24(3):253-260. PubMed ID: 33084419
    [Abstract] [Full Text] [Related]

  • 5. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss.
    Shi L, Ren L, Li J, Liu X, Lu J, Jia L, Xie B, Tang S, Liu W, Zhang J.
    Chin J Nat Med; 2024 Mar; 22(3):212-223. PubMed ID: 38553189
    [Abstract] [Full Text] [Related]

  • 6. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M, Shan J, Xu H, Xia G, Xu Q, Quan K, Liu X, Dai M.
    J Ethnopharmacol; 2021 Aug 10; 276():114176. PubMed ID: 33933570
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Piperlongumine, a Piper longum-derived amide alkaloid, protects mice from ovariectomy-induced osteoporosis by inhibiting osteoclastogenesis via suppression of p38 and JNK signaling.
    Luo N, Zhang L, Xiu C, Luo X, Hu S, Ji K, Liu Q, Chen J.
    Food Funct; 2024 Feb 19; 15(4):2154-2169. PubMed ID: 38311970
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL, Xu RS, Jiang DL, He XL, Su Q, Jin C, Li X.
    Bone; 2015 Jun 19; 75():128-37. PubMed ID: 25708053
    [Abstract] [Full Text] [Related]

  • 11. Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway.
    Wei G, Liang X, Wu F, Cheng C, Huang S, Zeng Y.
    PeerJ; 2024 Jun 19; 12():e17722. PubMed ID: 39006031
    [Abstract] [Full Text] [Related]

  • 12. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species.
    Wong P, Lv Z, Li J, Wei Q, Xu L, Fang B, Luo Y, He M.
    Oxid Med Cell Longev; 2022 Jun 19; 2022():5982014. PubMed ID: 36388169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J, Ning H, Wang M, Zhao W, Jing Y, Liu X, Zu J, Kong P, Wang X, Sun C, Yan J.
    Cell Signal; 2021 Nov 19; 87():110137. PubMed ID: 34469786
    [Abstract] [Full Text] [Related]

  • 15. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Hsiao HB, Lin H, Wu JB, Lin WC.
    Osteoporos Int; 2013 May 19; 24(5):1663-76. PubMed ID: 23143538
    [Abstract] [Full Text] [Related]

  • 16. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways.
    Cang D, Zou G, Yang C, Shen X, Li F, Wu Y, Ji B.
    J Pharmacol Sci; 2021 Aug 19; 146(4):206-215. PubMed ID: 34116734
    [Abstract] [Full Text] [Related]

  • 17. Based on NF-κB and Notch1/Hes1 Signaling Pathways, the Mechanism of Artesunate on Inflammation in Osteoporosis in Ovariectomized Rats was Investigated.
    Wang G, Tan J, Huang C, Xu Y, Yang Z, Huo L.
    Front Biosci (Landmark Ed); 2024 Jul 24; 29(7):266. PubMed ID: 39082354
    [Abstract] [Full Text] [Related]

  • 18. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
    Sun S, Xiu C, Chai L, Chen X, Zhang L, Liu Q, Chen J, Zhou H.
    Eur J Pharmacol; 2022 Jul 15; 927():175073. PubMed ID: 35636521
    [Abstract] [Full Text] [Related]

  • 19. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
    Kuang Z, Yang X, Cao Z, Li Y, Hu J, Hong X, Li B, Wu C, Qi Q, Liu X, Dai M.
    Int Immunopharmacol; 2023 Apr 15; 117():109884. PubMed ID: 36805201
    [Abstract] [Full Text] [Related]

  • 20. Osteoclastic miR-301-b knockout reduces ovariectomy (OVX)-induced bone loss by regulating CYDR/NF-κB signaling pathway.
    Zhu J, Wang H, Liu H.
    Biochem Biophys Res Commun; 2020 Aug 13; 529(1):35-42. PubMed ID: 32560816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.